Advertisement

Histopathological Assessment for Esophageal Squamous Cell Carcinoma

  • Alfred K. LamEmail author
Protocol
  • 52 Downloads
Part of the Methods in Molecular Biology book series (MIMB, volume 2129)

Abstract

Histological assessment of esophageal squamous malignancies is crucial for management of patients with the cancer as well as working in research on the cancer. The squamous malignancies in the esophagus comprise squamous dysplasia and squamous cell carcinoma. Current classification of squamous dysplasia in the esophagus is to divide it into low grade and high grade. Most of the esophageal squamous cell carcinomas are of conventional type and divided into well, moderately, and poorly differentiated. The variants of esophageal squamous cell carcinoma include basaloid squamous carcinoma, spindle cell carcinoma, and verrucous carcinoma. Preoperative chemoradiation is used commonly in the treatment of esophageal squamous cell carcinoma and induces changes in morphology. Tumor regression grading systems based on the percentage of the remaining carcinoma cells are used to assess the response to the neoadjuvant therapy in the cancer. Additional histological parameters including lymphovascular invasion, perineural invasion, clearance of resection margins, and carcinoma in the nodal and distant metastatic sites provide essential information for the management of the patient with the cancer.

Key words

Esophagus Squamous dysplasia Squamous cell carcinoma Basaloid squamous carcinoma Spindle cell carcinoma Grade Neoadjuvant therapy Pathology 

References

  1. 1.
    Lam KY, Ma L (1997) Pathology of esophageal cancers: local experience and current insights. Chin Med J 110:459–464PubMedGoogle Scholar
  2. 2.
    Lam KY, Law S, Wong J (2013) Low prevalence of incidentally discovered and early-stage esophageal cancers in a 30-year autopsy study. Dis Esophagus 16:1–3CrossRefGoogle Scholar
  3. 3.
    Rice TW, Kelsen D, Blackstone E, Ishwaran H, Patil DT, Bass AJ, Erasmus JJ, Gerdes H, Hofstetter WL (2016) Esophagus and esophagogastric junction. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (eds) Chapter 16: AJCC cancer staging manual, 8th edn. Springer, Berlin, pp 185–202Google Scholar
  4. 4.
    Lam KY, Ma LT, Wong J (1996) Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J Clin Pathol 49:124–129CrossRefGoogle Scholar
  5. 5.
    Wang J, Qin J, Jing S, Liu Q, Cheng Y, Wang Y, Cao F (2018) Clinical complete response after chemoradiotherapy for carcinoma of thoracic esophagus: is esophagectomy always necessary? A systematic review and meta-analysis. Thorac Cancer 9:1638–1647CrossRefGoogle Scholar
  6. 6.
    Lam AK, Ochiai A, Odze RD (2019) Tumours of the oesophagus: introduction. In: Odze RD, Lam AK, Ochiai A, Washington MK (eds) Chapter 2: WHO classification of tumours, 5th edn, pp 28–29Google Scholar
  7. 7.
    Li TJ, Zhang YX, Wen J, Cowan DF, Hart J, Xiao SY (2004) Basaloid squamous cell carcinoma of the esophagus with or without adenoid cystic features. Arch Pathol Lab Med 128:1124–1130PubMedGoogle Scholar
  8. 8.
    Lam KY, Law S, Luk JM, Wong J (2001) Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator. J Pathol 195:435–442CrossRefGoogle Scholar
  9. 9.
    Salami A, Abbas AE, Petrov R, Jhala N, Bakhos CT (2018) Comparative analysis of clinical, treatment, and survival characteristics of basaloid and squamous cell carcinoma of the esophagus. J Am Coll Surg 226:1086–1092CrossRefGoogle Scholar
  10. 10.
    Lam AK (2019) Oesophageal adenoid cystic carcinoma. In: Odze RD, Lam AK, Ochiai A, Washington MK (eds) Chapter 2: WHO classification of tumours, 5th edn, pp 44–45Google Scholar
  11. 11.
    Raza MA, Mazzara PF (2011) Sarcomatoid carcinoma of esophagus. Arch Pathol Lab Med 135:945–948PubMedGoogle Scholar
  12. 12.
    Lam KY, Law SY, Loke SL, Fok M, Ma LT (1996) Double sarcomatoid carcinomas of the oesophagus. Pathol Res Pract 192:604–609CrossRefGoogle Scholar
  13. 13.
    Iyomasa S, Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Itabashi M (1990) Carcinosarcoma of the esophagus: a twenty-case study. Jpn J Clin Oncol 20:99–106PubMedGoogle Scholar
  14. 14.
    Behrens A, Stolte M, Pech O, May A, Ell C (2014) Verrucous oesophageal carcinoma: single case report and case series including 15 patients—issues for consideration of therapeutic strategies. Viszeralmedizin 30:346–352CrossRefGoogle Scholar
  15. 15.
    Vieira CL, Lopes JC, Velosa J (2013) A case of esophageal squamous cell carcinoma with positive HPV 11. Gastroenterol Hepatol 36:311–315CrossRefGoogle Scholar
  16. 16.
    Tonna J, Palefsky JM, Rabban J, Campos GM, Theodore P, Ladabaum U (2010) Esophageal verrucous carcinoma arising from hyperkeratotic plaques associated with human papilloma virus type 51. Dis Esophagus 23:E17–E20PubMedGoogle Scholar
  17. 17.
    Cappellesso R, Coati I, Barzon L, Peta E, Masi G, Scarpa M, Lanza C, Michelotto M, Ruol A, Cesaro S, Castoro C, Palù G, Nuovo GJ, Fassan M, Rugge M (2019) Human papillomavirus infection is not involved in esophageal verrucous carcinoma. Hum Pathol 85:50–57CrossRefGoogle Scholar
  18. 18.
    Lam AK (2018) Histopathological assessment for esophageal adenocarcinoma. Methods Mol Biol 1756:67–76CrossRefGoogle Scholar
  19. 19.
    Lam KY, Dickens P, Loke SL, Fok M, Ma L, Wong J (1994) Squamous cell carcinoma of the oesophagus with mucin-secreting component (muco-epidermoid carcinoma and adenosquamous carcinoma): a clinicopathologic study and a review of literature. Eur J Surg Oncol 20:25–31PubMedGoogle Scholar
  20. 20.
    Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH (2010) Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17:2184–2192CrossRefGoogle Scholar
  21. 21.
    Chao YK, Chang CB, Chuang WY, Wen YW, Chang HK, Tseng CK, Yeh CJ, Liu YH (2015) Correlation between tumor regression grade and clinicopathological parameters in patients with squamous cell carcinoma of the esophagus who received neoadjuvant chemoradiotherapy. Medicine (Baltimore) 94:e1407CrossRefGoogle Scholar
  22. 22.
    Fujishima F, Taniyama Y, Nakamura Y, Okamoto H, Ozawa Y, Ito K, Ishida H, Konno-Kumagai T, Kasajima A, Taniuchi S, Watanabe M, Kamei T, Sasano H (2018) Residual carcinoma cells after chemoradiotherapy for esophageal squamous cell carcinoma patients: striving toward appropriate judgment of biopsy. Dis Esophagus 31:1–6CrossRefGoogle Scholar
  23. 23.
    Lam AK, Kumarasinghe MP (2019) Adenocarcinoma of the oesophagus and oesophagogastric junction NOS. In: Odze RD, Lam AK, Ochiai A, Washington MK (eds) Chapter 2: WHO classification of tumours, 5th edn, pp 38–43Google Scholar
  24. 24.
    Brown IS, Fujii S, Kawachi H, Lam AK, Saito T (2019) Oesophageal squamous cell carcinoma NOS. In: Odze RD, Lam AK, Ochiai A, Washington MK (eds) Chapter 2: WHO classification of tumours, 5th edn, pp 48–53Google Scholar
  25. 25.
    Lagarde SM, Phillips AW, Navidi M, Disep B, Immanuel A, Griffin SM (2015) The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence. Br J Cancer 113:1427–1433CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Cancer Molecular Pathology, School of MedicineGriffith UniversityGold CoastAustralia

Personalised recommendations